Philip Gutry - GRPH Old Chief Officer
| GRPHDelisted Stock | USD 2.67 0.05 1.84% |
Insider
Philip Gutry is Chief Officer of GRPH Old
| Age | 51 |
| Phone | 650 484 0886 |
| Web | https://graphitebio.com |
GRPH Old Management Efficiency
The company has return on total asset (ROA) of (0.1799) % which means that it has lost $0.1799 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5195) %, meaning that it created substantial loss on money invested by shareholders. GRPH Old's management efficiency ratios could be used to measure how well GRPH Old manages its routine affairs as well as how well it operates its assets and liabilities.GRPH Old currently holds 362 K in liabilities with Debt to Equity (D/E) ratio of 0.02, which may suggest the company is not taking enough advantage from borrowing. GRPH Old has a current ratio of 26.53, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about GRPH Old's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Solomon Langermann | NextCure | 65 | |
| Sumita JD | Instil Bio | 50 | |
| FMEDSCI MD | Achilles Therapeutics PLC | 49 | |
| MBA MBA | Sensei Biotherapeutics | 52 | |
| Oleg Nodelman | Nuvation Bio | 44 | |
| David Hanley | Nuvation Bio | 55 | |
| Elisabeth Colunio | Sensei Biotherapeutics | N/A | |
| Mark Dudley | Instil Bio | N/A | |
| Kim Blickenstaff | Nuvation Bio | 68 | |
| Robert Bazemore | Nuvation Bio | 53 | |
| Thomas Templeman | Nuvation Bio | 60 | |
| Michael MSBA | NextCure | 64 | |
| Robert MD | Sensei Biotherapeutics | 58 | |
| Jamie Moore | CytomX Therapeutics | N/A | |
| CPA CPA | NextCure | 61 | |
| Stacy Markel | Nuvation Bio | 60 | |
| Bronson Crouch | Instil Bio | 52 | |
| MHROD SHRMSCP | Assembly Biosciences | N/A | |
| Steven Fuller | Sensei Biotherapeutics | N/A | |
| Karl MD | Achilles Therapeutics PLC | 57 | |
| Timothy Mayer | NextCure | 60 | |
Management Performance
| Return On Equity | -0.52 | |||
| Return On Asset | -0.18 |
GRPH Old Leadership Team
Elected by the shareholders, the GRPH Old's board of directors comprises two types of representatives: GRPH Old inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GRPH. The board's role is to monitor GRPH Old's management team and ensure that shareholders' interests are well served. GRPH Old's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GRPH Old's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Stephanie Yao, Vice Relations | ||
| Maria MD, Academic Board | ||
| Christine PMP, Chief Operations | ||
| Jerry Cacia, Chief Officer | ||
| Philip Gutry, Chief Officer | ||
| Jane Grogan, Chief Officer | ||
| MD FACC, CEO Pres | ||
| Daniel Dever, CoFounder Research | ||
| Alethia Young, Chief Officer | ||
| Kimberlee CPA, CEO and Presidentident | ||
| Matthew MD, Academic Director |
GRPH Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is GRPH Old a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.52 | |||
| Return On Asset | -0.18 | |||
| Current Valuation | 1.88 M | |||
| Shares Outstanding | 58.24 M | |||
| Shares Owned By Insiders | 9.17 % | |||
| Shares Owned By Institutions | 84.40 % | |||
| Number Of Shares Shorted | 704.04 K | |||
| Price To Earning | 0.70 X | |||
| Price To Book | 1.01 X | |||
| EBITDA | (70.7 M) |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Consideration for investing in GRPH Stock
If you are still planning to invest in GRPH Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the GRPH Old's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |